Shares of Bellicum Pharmaceuticals plunged following an announcement that the company will slash 79% of employees as part of a restructuring following the developmental pause for one CAR-T program.

Syneos Health announced an agreement to acquire Synteract, a full-service contract research organization (CRO) focused on the biopharmaceutical industry.

Leading pharmaceutical companies – including Moderna, Pfizer and AstraZeneca – are racing ahead to develop and distribute a Covid-19 vaccine.

For the first time ever, Klick Health took its in-office flu shot clinic on the road in keeping with the company’s people-first culture and commitment to help keep team members and their families healthy and happy.

Novartis acquired Cambridge, Massachusetts-based Vedere Bio in a deal totaling up to $280 million.

W2O announced two new products available through Symplur, the company’s social media analytics platform dedicated exclusively to the healthcare industry.

Cerevel Therapeutics began trading on the Nasdaq.

Gilead Sciences Inc. cut the company’s 2020 revenue forecast, citing lower-than-expected demand and difficulty in predicting sales of remdesivir, the only treatment approved in the United States for patients hospitalized with Covid-19.

Shionogi & Co. is planning clinical trials by year-end 2020 for what may be one of Japan’s first domestically produced Covid-19 vaccines to reach the market, as the globe races to secure enough doses to battle the pandemic.

Amgen Inc. reported that third-quarter 2020 adjusted profit rose 17% due to stronger sales of drugs such as the osteoporosis treatment Prolia and the psoriasis medication Otezla, bucking challenges from lower drug prices and Covid-19.